CERN Cerner Corporation

Cerner Announces Appointment of Major General Elder Granger, M.D., United States Army (Retired) to Its Board of Directors

Cerner Announces Appointment of Major General Elder Granger, M.D., United States Army (Retired) to Its Board of Directors

CERNER EXPANDS BOARD TO 11 DIRECTORS

KANSAS CITY, Mo., Nov. 18, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: CERN) announced today that Major General Elder Granger, M.D., U.S. Army (retired) has been appointed to the company’s Board of Directors, effective Nov. 16, 2020. Dr. Granger, 67, is president and chief executive officer of The 5Ps, LLC, a health care, education and leadership consulting organization.

“It’s an honor to welcome Dr. Granger to our Board,” said Brent Shafer, Cerner’s chairman and chief executive officer. “He is a proven clinical, military and business leader who has successfully navigated complex policy, regulatory and competitive environments. He will bring invaluable insights to Cerner particularly in the commercial and federal health sectors. We are delighted to have him.”

By adding Dr. Granger, , with 10 of them, including Dr. Granger, being external and independent. Dr. Granger fills a newly created Class II Director seat and will stand for re-election at Cerner’s 2021 annual shareholder meeting.

Dr. Granger served in the U.S. Army for over 35 years before his retirement on July 1, 2009. During his military career he held significant roles including the deputy director and program executive officer of the TRICARE Management Activity, Office of the Assistant Secretary of Defense (Health Affairs) in Washington, D.C. Prior to joining TRICARE Management Activity, Dr. Granger led the largest U.S. and multi-national battlefield health system in recent history while serving as Commander, Task Force 44th Medical Command and Command Surgeon for the Multinational Corps Iraq. He has led at every level of the Army Medical Department.

In addition to his accomplished military career, Dr. Granger is board-certified by the American Board of Internal Medicine and the Board of Hematology and Oncology, a certified physician executive by the Certifying Commission in Medical Management, certified by the American College of Healthcare Executives and certified in Medical Quality by the American Board of Medical Quality. He has earned the CERT Certificate in Cybersecurity Oversight from Carnegie Mellon University, certified in Healthcare Compliance by Health Care Compliance Association and is a certified Compliance Officer by American Academy of Professional Coders. Dr. Granger also serves on the boards of directors of Cigna Corporation (NYSE:CI) and DLH Holdings Corporation (NASDAQ: DLHC).

“The opportunity to bring on a person of this caliber not only is another step in improved corporate governance, it also adds another dimension of experience that complements our current Board members’ skills,” said Shafer.

About Cerner

’s health technologies connect people and information systems at thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people. For more information, visit ,  or connect on , , ,  or . Nasdaq: CERN. Health care is too important to stay the same.

Media Contacts:

Cerner

Misti Preston, Director, External Communications & Public Relations,

A photo accompanying this announcement is available at



EN
18/11/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cerner Corporation

CERNER sees an upgrade to Slightly Positive due to a better fundamenta...

The general evaluation of CERNER (US), a company active in the Software industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date December 14, 2021, the closing price was USD 77.26 and...

 PRESS RELEASE

Cerner Announces Increased Quarterly Dividend

Cerner Announces Increased Quarterly Dividend Dividend of $0.27 per issued and outstanding share reflects 23% increase KANSAS CITY, Mo., Dec. 10, 2021 (GLOBE NEWSWIRE) --  (NASDAQ: CERN), a global healthcare technology company, today announced that its board of directors declared a cash dividend to stockholders of $0.27 per issued and outstanding share, up 23 percent from the prior quarterly dividend of $0.22. The cash dividend will be payable January 11, 2022, to shareholders of record as of the close of business December 27, 2021. Cerner intends to pay regular quarterly cash dividend...

 PRESS RELEASE

Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Offic...

Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Officer Experienced Clinical Executive to Lead Patient and Caregiver Experiences KANSAS CITY, Mo., Nov. 16, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global healthcare technology company, today announced Nasim Afsar, MD, MBA, MHM, as the company’s first Chief Health Officer, effective January 2022. In this new role, Dr. Afsar will lead Cerner’s more than 1,000 healthcare professionals who provide insight and guidance to product development and improving the lives of patients and caregivers. She will also lead the quality...

 PRESS RELEASE

Cerner Reports Third Quarter 2021 Results

Cerner Reports Third Quarter 2021 Results Delivers Strong Results Across Key MetricsGAAP Operating Margin and Diluted EPS Lower; Adjusted Operating Margin and Adjusted Diluted EPS Both up Sharply vs. Year-Ago QuarterFull-Year Guidance Increased KANSAS CITY, Mo., Oct. 29, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: CERN) today announced results for the 2021 third quarter that ended September 30, 2021. The third quarter 2021 earnings release can be viewed as well as on the company’s website at . Cerner will host an earnings conference call to provide additional detail on the Company’s results a...

 PRESS RELEASE

Cerner Enviza Aims To Accelerate Therapies And Improve Patient Outcome...

Cerner Enviza Aims To Accelerate Therapies And Improve Patient Outcomes Combining decades of healthcare, life sciences and collaborative research to transform the way care is delivered KANSAS CITY, Mo., Oct. 26, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global healthcare technology company, announces the launch of a new operating unit, SM, that offers data-driven solutions and research services to help bring clarity to multi-dimensional data through real-world evidence and insights. The combined expertise of the Cerner and Kantar Health teams is expected to help accelerate discovery, ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch